Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
about
Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthmaLong-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthmaLong-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthmaAddition of anti-leukotriene agents to inhaled corticosteroids for chronic asthmaAdd-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive reviewClinical asthma phenotypes in the real world: opportunities and challengesApproach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), IranBronchial thermoplasty in asthma: current perspectivesDoes zafirlukast reduce future risk of asthma exacerbations in adults? Systematic review and meta-analysisRecent advances in the management of asthma using leukotriene modifiersThe effects of zafirlukast on capsular contracture: preliminary reportNational Athletic Trainers' Association position statement: management of asthma in athletes.Recent advances: Respiratory medicine.Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence.Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.Asthma, airway biology, and allergic rhinitis in AJRCCM 2000.Relationship between asthma drug therapy patterns and healthcare utilization.Management of asthma in adults: current therapy and future directionsCombination therapy: appropriate for everyone?Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthmaEffect of montelukast added to inhaled budesonide on control of mild to moderate asthmaAsthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthmaLeukotriene receptor antagonists--risks and benefits for use in paediatric asthma.Current and emerging nonsteroidal anti-inflammatory therapies targeting specific mechanisms in asthma and allergy.PILL Series. The 'problematic' asthma patientSevere asthma in children.Exhaled nitric oxide in paediatric asthma.The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and childrenThe Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.Tolerance and rebound with zafirlukast in patients with persistent asthmaThe Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1Early achievement and maintenance of stable asthma control using initially higher-dose inhaled corticosteroids as part of combination therapy: an open-label pilot study.An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.Montelukast in guidelines and beyond.Asthma care practicing among general practitioners in Lebanon: a cross-sectional studyModerate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma.Emerging interleukin receptor antagonists for the treatment of asthma.Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.Step 4: stick or twist? A review of asthma therapy.Addition to inhaled corticosteroids of leukotriene receptor antagonists versus theophylline for symptomatic asthma: a meta-analysis.
P2860
Q24197585-73A56A55-9FE5-47F1-B8A9-1B90A5142FDBQ24244152-7CF70610-371D-47DB-9207-DEED347B7B7CQ24245147-B4A12EA2-2A0F-4190-9F97-0D272B46CDACQ24247489-C2991F49-C2FA-4E90-B634-A1B388795637Q24794527-A7772006-B523-4181-85CB-BAB84E879821Q26775236-090AA5A0-A5A2-466A-A12A-ACDB71314851Q26777154-10BB1FB8-8B30-4F55-AA6C-996844B42072Q26852643-89552D49-AD6F-42C8-B27D-181540C0F2BFQ26863510-197BE3EB-B48B-4859-92A7-BDF1AC9A5B19Q28166742-782D94E1-640D-45B3-BDC0-3D5D29EDA0BAQ28263876-25345C67-7409-4CD6-9689-5409BFA4453FQ28769235-7946C37C-FCBD-4A1D-80EA-64D3CF2EEC60Q33808282-C9425AC6-4E73-401C-A01F-380BE26E2D91Q33877940-C468E52F-DF77-455F-90B9-A4EE51470AAAQ34424227-FA3A1D03-4E94-4EBF-891A-49934745EAF0Q34446626-23BFBECA-A664-4767-9E91-47773B836C65Q34579601-475F7293-9CE0-4957-9860-94805C53342CQ35143482-23DBD000-B287-4AD1-BC96-885707D2766DQ35180953-42F6AFCD-A089-40C9-BBCB-FAB13A798AFDQ35535752-790FD77B-7907-484C-B4B7-E58BBB56448FQ35535801-EFF86108-E041-423D-96AF-7482F1F6429AQ35577966-A9B3C330-6484-4918-9816-11A5D657C78BQ35779312-F72185F4-6883-4E52-B85E-EC461BCF4547Q35879047-6D4B4A97-5CF4-446A-86AF-682CF487AB6AQ35905019-67482FF6-0BDF-4BB2-B6B8-706CA656F572Q36108246-40E2A192-A4D1-4560-A8F5-5F454E619B87Q36310751-83C3CBA7-6136-4E34-BCD5-F37D75A1272AQ36422663-25F5BF5F-9AB1-402D-AEB8-9F7A12D91D6EQ36566081-0ABDBFA9-9118-40A9-BC1E-6EC1CA015679Q36717710-C797D076-D678-4847-936A-117DD850E54BQ36929333-C19F2464-C08B-49D6-8F4B-065785E8E2CAQ36954589-4D2F2768-0167-48DA-A0D4-4D5125AAC80EQ37522916-C1D7B5BC-DEE3-4B72-B297-2F4DCCB279AAQ37534372-4FDEC19C-5D62-4322-835F-31EE6829796FQ37552495-12E230C5-9719-4A4D-B248-5270ED32FA25Q38091461-500F6734-4BC9-4FAE-82F8-36DE98FF0CCFQ38638355-A4A28EC9-1BAC-43D3-8719-E4678812B224Q38903489-9493ED4B-75E6-4385-988F-D11EB85EB1F8Q38960423-80BCF25A-0248-46EA-9DB2-A9F78C7F83D2Q40253047-54EEFB60-3F74-4C18-8915-8A7FF3D07BEB
P2860
Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.
@en
Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.
@nl
type
label
Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.
@en
Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.
@nl
prefLabel
Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.
@en
Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.
@nl
P2093
P2860
P1476
Zafirlukast improves asthma co ...... -dose inhaled corticosteroids.
@en
P2093
P2860
P304
P356
10.1164/AJRCCM.162.2.9905041
P407
P433
P577
2000-08-01T00:00:00Z